Immunic (IMUX) EPS (Basic) (2013 - 2026)

Immunic (IMUX) reported EPS (Basic) of -$1.19 for Q1 2026, up 54.83% on a YoY basis from -$0.77 in Q1 2025, and up 20.74% sequentially from -$1.5 in Q4 2025.

Immunic (IMUX) EPS (Basic) (2013 - 2026) Analysis & Trends

Immunic (IMUX) has 14 years of EPS (Basic) data on file, last reported at -$1.19 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) rose 54.83% year-over-year to -$1.19; the trailing twelve-month figure through Mar 2026 stood at -$3.74 (up 62.65% YoY), and the FY2025 full-year result was -$14.26, up 32.52% from the prior year.
  • EPS (Basic) improved to -$1.19 in Q1 2026, from -$1.5 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$1.19 in Q1 2026 to a low of -$40.76 in Q4 2022.
  • A 5-year average of -$6.07 and a median of -$2.74 in 2024 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) decreased 19.72% in 2022 and jumped 86.79% in 2023, its largest moves.
  • Tracing IMUX's EPS (Basic) over 5 years: stood at -$40.76 in 2022, then jumped by 86.79% to -$5.38 in 2023, then soared by 53.19% to -$2.52 in 2024, then jumped by 40.51% to -$1.5 in 2025, then advanced by 20.74% to -$1.19 in 2026.
  • Business Quant data shows IMUX's EPS (Basic) at -$1.19 in Q1 2026, -$1.5 in Q4 2025, and -$1.37 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.16
4 NuCana 279.75 Bn 279.75 Bn - 0.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.99
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.59
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Immunic 11.03 Mn 11.03 Mn - -1.19

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.19
Dec 31, 2025 -1.50
Sep 30, 2025 -1.37
Jun 30, 2025 -2.04
Mar 31, 2025 -2.63
Dec 31, 2024 -2.52
Sep 30, 2024 -2.74
Jun 30, 2024 -2.15
Mar 31, 2024 -2.38
Dec 31, 2023 -5.38
Sep 30, 2023 -5.14
Jun 30, 2023 -5.90
Mar 31, 2023 -6.09
Dec 31, 2022 -40.76
Sep 30, 2022 -6.51
Jun 30, 2022 -6.79
Mar 31, 2022 -8.14
Dec 31, 2021 -34.04
Sep 30, 2021 -7.29
Jun 30, 2021 -9.00